One important aspect of the "who knew what and when" story related to Schering-Plough executives selling massive amounts of SP stock in 2007 is that while the treatment arms of the Vytorin trial were blinded, the treatment effect on the primary end point—change in mean carotid intima-media thickness (CIMT) after two years—was similar in the Zocor (simvastatin-alone) and Vytorin (ezetimibe/simvastatin-combination) groups.
Some cardiologists believe that unblinding the results would have been unnecessary to know the treatment effect was neutral:
Chart courtesy of PharmaGossip.
"Somebody had looked at the end-point examination, the IMT results, and, irrespective of group assignment, could know that a groupwise comparison of CIMT changes showed no statistically significant difference," Dr Allen Taylor (Walter Reed Army Medical Center, Washington, DC) told heartwire. "In my view, once that is known, the trial is functionally unblinded."
Taylor, a researcher involved in numerous clinical trials, including his role as the lead investigator of the Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER-2) CIMT study, stressed that he has no inside knowledge of when the end-point analysis was completed and does not know whether company officials looked at the blinded data, although he believes it that remains open to speculation.
He said it would be difficult to look across all the data without assigning patients to treatment groups and make any sense of presumed outliers. He added that the 18-month gap after the trial was completed and the reporting of the results leaves the companies wide open to question, especially Merck/Schering Plough's contention that they sought to address quality issues with the images.
"Their sequence of actions to rehabilitate the data is in many ways a signal of distress," said Taylor. "What was fueling that? I can see some may readily speculate that it seems highly implausible that 18 months were spent working on the data without there being a reason related to the overall trial results being known to be negative."



I'm not at all sure I believe that. I've just tried simulating some data to see how obvious a group difference would be on unblinded data.
The difference between treatments would have to be pretty big before you could spot it on unblinded data, and probably much bigger than anyone would reasonably expect in a trial. I simulated data for 1000 patients with a between group difference in a continuous outcome variable equal to the standard deviation of the variable. That's a bigger difference than you would normally expect to see in a clinical trial (although I don't know what difference they were looking for here). This histogram of all the combined data was visually indistinguishable from a normal distribution. The data even passed the Shapiro-Wilk test for the normality of the distribution, even though it was technically bimodal.
So I don't believe that you could look at a distribution on blinded data and rule out a significant difference, just because the distribution looks like the topmost of the 3 curves above.
Posted by: Adam | February 01, 2008 at 04:43 AM
Adam is correct. You are looking here at the distribution of individual patient results. The treatment-group means are more tightly distributed, by roughly the square root of the number of patients in the trial. (That's about 55x for a 3,000-patient trial) So it is possible to have a very robust treatment effect and still have a unimodal curve.
On the other hand, seeing a bimodal curve in the blinded data would indicate that there's a treatment effect, unless there's a reason for the underlying data to be bimodal. So "blind" isn't really blind, but only if you see two humps.
Posted by: Alan | February 04, 2008 at 09:03 AM
Hey, great post, very well written. You should post more about this.
Posted by: cheap darkfall gold | July 14, 2009 at 09:46 PM
thank you for sharing,i like.
Posted by: darkfall gold | December 23, 2009 at 03:40 AM
We can put forward a contract that says we want something for nothing, but at the end of the day that’s just not going to wor
Posted by: darkfall gold | December 24, 2009 at 03:11 AM
We can put forward a contract that says we want something for nothing, but at the end of the day that’s just not going to wor
Posted by: dungeon fighter gold | December 24, 2009 at 03:11 AM
Don't have cash to buy some real estate? Do not worry, because that's possible to get the personal loans to resolve such problems. Hence take a consolidation loan to buy everything you want.
Posted by: JodiKirk30 | April 04, 2010 at 07:31 PM
I'm in:)
Posted by: wow card | May 09, 2010 at 10:56 PM
Those findings appear to be supported by further research showing that physicians, especially general or family practitioners, expect to decrease their use of Vytorin as a first- and second-line treatment option in patients with hypercholesterolemia.
Posted by: cheapest generic viagra | July 17, 2010 at 05:23 AM
I always prefer to read article on cardiology. That is my favorite subject.
I have read this article it is very effective I would like to few more article from you keep working patiently. I would follow you just like Hutch mobile.
Our network will follow you.
hahahahaha
.........Alex
Posted by: generic viagra no prescription | July 23, 2010 at 02:31 AM
I'm not at all sure I believe that. I've just tried simulating some data to see how obvious a group difference would be on unblinded data.
Posted by: Generic Viagra | August 01, 2010 at 02:57 PM
sada
Posted by: asd | September 06, 2010 at 02:34 PM
While outlining the path of inference that Senator Grassley first forged, back in February of 2008 (to deduce that Schering had acheived "functional unblinding" of the ENHANCE data), the plaintiffs, again in Manson (Case 08-397), offer perhaps the most succinct piece of skepticism
Posted by: Online Pharmacy | December 02, 2010 at 06:56 AM
Hi, great article. The way you explained it is really awesome and makes every one to read till the end. keep posting..
Posted by: dugis wow guide | December 24, 2010 at 10:23 AM
Awesome post! please keep up the great work i would love to hear more like this.
Posted by: Indian pharmacy | February 21, 2011 at 04:07 AM
Great web site. Than you for the information his site is amazing. Very well developed with great information.
Posted by: bob kesto | February 21, 2011 at 04:08 AM
This is a very great idea. Thank you for this insightful and useful article.
Posted by: Buy Darvocet | February 26, 2011 at 07:29 AM
Excellent post. I was checking constantly this blog and I’m impressed! Very useful information particularly the last part :) I care for such information much. I was looking for this certain information for a long time. Thank you and good luck.
Posted by: Buy Cymbalta | February 26, 2011 at 07:38 AM
Thanks for the nice blog. It was very useful for me. Keep sharing such ideas in the future as well. This was actually what I was looking for, and I am glad to came here! Thanks for sharing the such information with us.
Posted by: Buy Lasix Online | February 26, 2011 at 07:39 AM
You raise a lot of questions in my head; you wrote an excellent post, but this post is also mind provoking, and I will have to think about it a bit more; I will return soon.
Posted by: buy lomotil | April 23, 2011 at 07:07 AM
Great stuff from you, man. I've read your stuff before and you're just too awesome. I love what you've got here, love what you're saying and the way you say it. You make it entertaining and you still manage to keep it smart. I cant wait to read more from you. This is really a great blog.
Posted by: buy zithromax | April 30, 2011 at 03:23 AM
巨人倍増 販売:http://www.001kanpo.com/product/12.html
RU486:http://www.001kanpo.com/product/121.html
MaxMan:http://www.001kanpo.com/product/29.html
威哥王:http://www.001kanpo.com/product/55.html
威哥王 販売:http://www.001kanpo.com/product/55.html
天天素:http://www.001kanpo.com/product/17.html
曲美:http://www.001kanpo.com/product/19.html
Posted by: 精力剤 | May 05, 2011 at 06:19 AM
福源春:http://www.hellokanpo.com/view/fuyuanchun.html
壮三天:http://www.hellokanpo.com/view/zhuangsantian.html
福源春 カプセル:http://www.hellokanpo.com/view/fuyuan-chun.html
女性用媚薬:http://www.hellokanpo.com/view/fuyuan-chun.html
五便宝:http://www.hellokanpo.com/view/wodibo-capsules.html
五便宝カプセル:http://www.hellokanpo.com/view/wodibo-capsules.html
VigRx Oil:http://www.hellokanpo.com/view/Oil.html
ビグレックス オイル:http://www.hellokanpo.com/view/Oil.html
Posted by: 精力剤 | May 05, 2011 at 06:22 AM
MAX MAN:http://www.specialitybrand.com/product/maxman.html
Satibo:http://www.specialitybrand.com/product/satibo.html
Wodibo:http://www.specialitybrand.com/product/wodibocapsule.html
Ant King:http://www.specialitybrand.com/product/antking.html
MOGEN:http://www.specialitybrand.com/product/mogencapsule.html
flower yilly:http://www.specialitybrand.com/product/huachi.html
Absolute climax:http://www.specialitybrand.com/product/absoluteclimax.html
Vigrx online:http://www.specialitybrand.com/product/vigrx.html
Posted by: MAX MAN | May 05, 2011 at 06:26 AM
wow this is such a nice article about this danger disease....
so much people caused by this disease
Posted by: online steroids | May 27, 2011 at 02:35 AM